Surgery – Means for introducing or removing material from body for... – Infrared – visible light – ultraviolet – x-ray or electrical...
Reexamination Certificate
2000-10-18
2003-05-06
Look, Edward K. (Department: 3745)
Surgery
Means for introducing or removing material from body for...
Infrared, visible light, ultraviolet, x-ray or electrical...
C604S501000
Reexamination Certificate
active
06560483
ABSTRACT:
FIELD OF THE INVENTION
The present invention is related generally to medical devices. More specifically, the present invention is related to skin patches for drug or medicant delivery.
BACKGROUND OF THE INVENTION
Systems for delivering ionized drugs through the skin have been known for many years. The application of an electrical field to the skin has been found to greatly enhance the skin's permeability to various ionic agents. In general, iontophoretic methods include the introduction of various ions into tissues through the skin by means of electricity. Additionally, applying an electrical current to the area around a wound has been found to improve wound healing. Iontophoretic techniques have been used to deliver some drugs, thus eliminating the requirement for hypodermically injecting these drugs. The elimination of the requirement for hypodermic injection can reduce or eliminate the associated problems of pain, trauma, and infection to the patient.
The manufacture and use of conventional iontophoretic patches is well known to those skilled in the art. In particular, Flower discusses iontophoretic controllers, patches, and electrodes in U.S. Pat. Nos. 5,668,231, 5,830,175, 5,876,368, 6,009,344, 6,047,208, and 6,018,680. Manufacture of patches is discussed by Green et al. in U.S. Pat. No. 5,682,726. Electrodes and patch discussions are included in U.S. Pat. No. 5,651,768 (Sibalis), U.S. Pat. No. 6,038,464 (Axelgaard et al.), and U.S. Pat. No. 5,458,569 (Kirk, III et al.). Iontophoresis, including polymeric carriers, delivery vehicles, and medicants, are discussed by Keith in U.S. Pat. No. 4,542,013, by D'Angelo et al. in U.S. Pat. No. 6,024,975, and by Powers et al. in U.S. Pat. No. 4,702,732. All of the aforementioned patents, which include subject matter in addition to that specifically cited above, are herein incorporated by reference in their entirety.
Iontophoresis is an active method for transdermal delivery of medicants. Active delivery methods may be distinguished from passive delivery methods. Passive methods rely on natural forces and pressures alone such as diffusion or concentration gradients. Conventional drug delivery skin patches are examples of passive delivery vehicles. Active methods use externally applied forces, for example, electrical potential or hydraulic forces, to force a medicant into the skin. Iontophoretic patches are active delivery vehicles for medicants.
Prior art iontophoretic analgesic or anesthetic devices have been limited in use to broad area application of an anesthetizing agent, for example, an anesthetic gel. One drawback of existing devices is that they must be applied directly over the target area. This has been undesirable as the target area cannot be viewed during application of the anesthetic, and the patch must be removed to view the target area. Once the patch is removed to access the site, delivery of the anesthetic stops. This creates a likelihood that the anesthesia will wear off as the procedure progresses, causing increased pain. In order to continue, the treating physician must either reapply the patch and wait for it to take effect, inject the site with local anesthetic, continue the procedure in spite of the increasing pain, or convert to general anesthesia.
Another problem with prior art devices, where the target area includes a wound, is that the anesthetic gel is placed directly on the target area. This creates a possibility that the anesthetic gel will contaminate the wound, cause infection or inflammation, or hinder the healing of the wound. One prior art method avoids this problem by using a field block. Local anesthesia may be achieved by making several injections in the area surrounding the target site, thus creating what is commonly referred to as a field block. A field block procedure may be fairly painful in itself, and may traumatize the patient, particularly a child.
After removal of prior art delivery patches, or after completion of the field block, there is no fail-safe method for determining where the anesthetized area begins or ends. This creates the potential for continuing a procedure into an un-anesthetized area, causing pain to the patient.
What would be desirable is a medical device capable performing local anesthesia without many of the aforementioned limitations.
SUMMARY OF THE INVENTION
The present invention includes a patch for transdermal application of a medicant, where the patch includes a border portion disposed about an aperture. The border portion can include a first polarity electrode in electrical communication with the medicant, and a second electrode having a second polarity opposite the first electrode polarity. One patch has a liftable cover, preferably a transparent and non-adherent cover, disposed over the patch aperture. A preferred medicant for inclusion in the present invention is a local anesthetic or analgesic. Some embodiments have single-part electrodes disposed on one side of the opposite polarity electrode, while other embodiments have two-part electrodes, with each part disposed on opposite sides of the opposite polarity electrode. Another embodiment includes a single polarity patch electrode to be used with an opposite polarity external electrode.
The present invention allows for performing a field block anesthetic about an epidermal target site. Patches according to the present invention can be used to actively deliver an anesthetic substance to a region bordering the target site, without requiring delivery under fluid pressure, or delivery requiring mechanical penetration, into the epidermis.
The present invention allows for observing a target or treatment site while leaving the patch in place. An invasive medical procedure can be performed through the patch aperture, and pre-operative and post-operative procedures can also be performed through the patch aperture. In one application of the present invention, local anesthetic may be iontophoretically applied around a burn or wound, allowing for pain management local to the wound, while leaving the wound observable and treatable through a liftable, transparent cover. In another application of the present invention, an iontophoretic patch may be applied, and anesthetic delivered before, during, and after a surgical incision, with the incision wound observable after the procedure through a transparent, liftable cover.
REFERENCES:
patent: 4542013 (1985-09-01), Keith
patent: 4702732 (1987-10-01), Powers et al.
patent: 5458569 (1995-10-01), Kirk, III et al.
patent: 5589180 (1996-12-01), Hind
patent: 5651768 (1997-07-01), Sibalis
patent: 5682726 (1997-11-01), Green et al.
patent: 5688231 (1997-11-01), Flower
patent: 5709869 (1998-01-01), Hind
patent: 5830175 (1998-11-01), Flower
patent: 5876368 (1999-03-01), Flower
patent: 6009344 (1999-12-01), Flower et al.
patent: 6018679 (2000-01-01), Dinh et al.
patent: 6018680 (2000-01-01), Flower
patent: 6024975 (2000-02-01), D'Angelo et al.
patent: 6038464 (2000-03-01), Axelgaard et al.
patent: 6047208 (2000-04-01), Flower
patent: 6167302 (2000-12-01), Millot
patent: 6383511 (2002-05-01), Cassel
Johnson Larry D.
Kumar Matthew M.
Fredrikson & Byron , P.A.
Look Edward K.
McCoy Kimya N
Minnesota High-Tech Resources, LLC
LandOfFree
Iontophoretic delivery patch does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Iontophoretic delivery patch, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Iontophoretic delivery patch will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3040079